Trial intelligence / Profile preview

Dipyridamole effect on metformin pharmacokinetics

NL-OMON37582Phase 4Recruiting

Sponsor
Radboud University Medical Center
Start
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of metformin and dipyridamole (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Metformin plasma AUC and Metformin Cmax. Started Apr 2012; status: recruiting.

02

Drugs

metformindipyridamole

Beyond the preview

Go deeper on NL-OMON37582.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON37582.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call